See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 11 2008

Multiple Sclerosis Rhinitis, Allergic, Perennial Addictions

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Multiple Sclerosis

If you have a relapsing form of MS, screening EDSS score below 6.0, at least one clinical relapse in the 12 months before screening, and have failed prior treatment with beta-interferon, you may qualify for this study.

The research site is in Nashville, Tenn.

More information

Please see


Rhinitis, Allergic, Perennial

If you have a history of seasonal allergic rhinitis symptoms and a positive skin test of at least one grass allergen, you may qualify for this study. Women of childbearing potential must use a medically acceptable form of contraception.

The research site is in Orange, Calif.

More information

Please see



If you are at least 18, and are able to provide at least four urine samples in a two-week period -- at least one of which is positive for methamphetamine -- you may qualify for this study.

The research site is in Lake Charles, La.

More information

Please see


Copyright 2008 CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.